Industry Resources | August 24, 2021
Concerns Persist About Opioid Overdoses & Medicare Beneficiaries’ Access To Treatment & Overdose-Reversal Drugs
On August 10, 2021, the U.S. Department of Health and Human Services' (DHS') Office of Inspector General (OIG) published this data brief regarding persistent concerns about opioid overdoses and Medicare Beneficiaries' access to treatment and overdose-reversal drugs. In the data brief, the OIG recommends that CMS to closely monitor the number of Medicare beneficiaries receiving medication-assisted treatment (MAT) drugs and naloxone and take action, if needed . . .